Literature DB >> 7788171

Adult onset Still's disease in northern India: comparison with juvenile onset Still's disease.

S S Uppal1, I R Pande, A Kumar, S Kailash, N G Sekharan, C M Adya, A N Malaviya.   

Abstract

The present study compared the clinical and laboratory picture, the disease course and outcome in 31 patients having adult onset Still's disease (AOSD) with 23 patients having juvenile onset Still's disease (JOSD). The median age at disease onset was 20 and 7 yr for AOSD and JOSD patients, respectively. On analysing and comparing our data on these two groups, no significant differences emerged except that adults had a significantly lower time interval from disease onset to remission as compared to juveniles. Upon comparison of data on our AOSD patients with that published from abroad, rash, adenopathy and sore throat were less frequent. No clinical or laboratory variables were found to predict the subsequent disease course and outcome in either group. The functional outcome was good in about 70% of both groups and mortality was low. It is concluded that the clinical picture and outcome in AOSD is similar to that of JOSD.

Entities:  

Mesh:

Year:  1995        PMID: 7788171     DOI: 10.1093/rheumatology/34.5.429

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  15 in total

1.  Clinico-immunological profile in juvenile rheumatoid arthritis--an Indian experience.

Authors:  V Seth; S K Kabra; O P Semwal; Y Jain
Journal:  Indian J Pediatr       Date:  1996 May-Jun       Impact factor: 1.967

2.  Therapeutic responses and prognosis in adult-onset Still's disease.

Authors:  Hyoun-Ah Kim; Jun-Mo Sung; Chang-Hee Suh
Journal:  Rheumatol Int       Date:  2011-01-29       Impact factor: 2.631

3.  Prolonged remission in adult-onset Still's disease with etanercept.

Authors:  Rakesh Kumari; Sukhbir S Uppal
Journal:  Clin Rheumatol       Date:  2005-04-23       Impact factor: 2.980

4.  A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis.

Authors:  Salih Pay; Nuran Türkçapar; Mukaddes Kalyoncu; Ismail Simşek; Esin Beyan; Ihsan Ertenli; M Akif Oztürk; Nurşen Düzgün; Hakan Erdem; Zeynep Ozbalkan; Sedat Kiraz; Gülay Kinikli; Nesrin Besbas; Ayhan Dinç; Aşkin Ateş; Umit Olmez; Meral Calgüneri; Olcay Tiryaki Aydintuğ; Ayşin Bakkaloğlu; Mustafa Turan; Murat Turgay; Yaşar Karaaslan; Rezzan Topaloğlu; Murat Duman; Seza Ozen
Journal:  Clin Rheumatol       Date:  2005-12-20       Impact factor: 2.980

Review 5.  Pathogenesis of adult-onset Still's disease: new insights from the juvenile counterpart.

Authors:  Yvan Jamilloux; Mathieu Gerfaud-Valentin; Fabio Martinon; Alexandre Belot; Thomas Henry; Pascal Sève
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

6.  Ten years of clinical experience with adult onset Still's disease: is the outcome improving?

Authors:  Sukhbir Singh Uppal; Moudhi Al-Mutairi; Sawsan Hayat; Mini Abraham; Anand Malaviya
Journal:  Clin Rheumatol       Date:  2006-11-04       Impact factor: 3.650

Review 7.  Treatment of adult-onset Still's disease: a review.

Authors:  Yvan Jamilloux; Mathieu Gerfaud-Valentin; Thomas Henry; Pascal Sève
Journal:  Ther Clin Risk Manag       Date:  2014-12-22       Impact factor: 2.423

8.  Adult-onset Still disease: a rare disorder with a potentially fatal outcome.

Authors:  Roberta Priori; Serena Colafrancesco; Angelica Gattamelata; Manuela Di Franco; Ugo Di Tondo; Guido Valesini
Journal:  Auto Immun Highlights       Date:  2010-07-10

9.  Application of the Yamaguchi criteria for classification of "suspected" systemic juvenile idiopathic arthritis (sJIA).

Authors:  Sharath Kumar; Divya Shree Kunhiraman; Lalitha Rajam
Journal:  Pediatr Rheumatol Online J       Date:  2012-11-23       Impact factor: 3.054

10.  Gene-expression analysis of adult-onset Still's disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity.

Authors:  Nanguneri Nirmala; Arndt Brachat; Eugen Feist; Norbert Blank; Christof Specker; Matthias Witt; Jan Zernicke; Alberto Martini; Guido Junge
Journal:  Pediatr Rheumatol Online J       Date:  2015-11-20       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.